Genetic heterogeneity of neuronal intranuclear inclusion disease: What about the infantile variant?
Language English Country United States Media print-electronic
Document type Letter, Research Support, Non-U.S. Gov't, Comment
PubMed
33780169
PubMed Central
PMC8045947
DOI
10.1002/acn3.51332
Knihovny.cz E-resources
- MeSH
- Genetic Heterogeneity * MeSH
- Intranuclear Inclusion Bodies MeSH
- Humans MeSH
- Neurodegenerative Diseases * genetics MeSH
- Check Tag
- Humans MeSH
- Publication type
- Letter MeSH
- Comment MeSH
- Research Support, Non-U.S. Gov't MeSH
See more in PubMed
Chen Z, Yan Yau W, Jaunmuktane Z, et al. Neuronal intranuclear inclusion disease is genetically heterogeneous. Ann Clin Transl Neurol. 2020;7(9):1716–1725. PubMed PMC
Sone J, Mitsuhashi S, Fujita A, et al. Long‐read sequencing identifies GGC repeat expansions in NOTCH2NLC associated with neuronal intranuclear inclusion disease. Nat Genet. 2019;51(8):1215–1221. PubMed
Ishiura H, Shibata S, Yoshimura J, et al. Noncoding CGG repeat expansions in neuronal intranuclear inclusion disease, oculopharyngodistal myopathy and an overlapping disease. Nat Genet. 2019;51(8):1222–1232. PubMed
Tian Y, Wang JL, Huang W, et al. Expansion of human‐specific GGC repeat in neuronal intranuclear inclusion disease‐related disorders. Am J Hum Genet. 2019;105(1):166–176. PubMed PMC
Deng J, Gu M, Miao Y, et al. Long‐read sequencing identified repeat expansions in the 5'UTR of the NOTCH2NLC gene from Chinese patients with neuronal intranuclear inclusion disease. J Med Genet. 2019;56(11):758–764. PubMed
Jedlickova I, Pristoupilova A, Hulkova H, et al. NOTCH2NLC CGG repeats are not expanded and skin biopsy was negative in an infantile patient with neuronal intranuclear inclusion disease. J Neuropathol Exp Neurol. 2020;79(10):1065–1071. PubMed
Takahashi‐Fujigasaki J. Neuronal intranuclear hyaline inclusion disease. Neuropathology. 2003;23(4):351–359. PubMed
Mano T, Takizawa S, Mohri I, et al. Neuronal intranuclear hyaline inclusion disease with rapidly progressive neurological symptoms. J Child Neurol. 2007;22(1):60–66. PubMed
McFadden K, Hamilton RL, Insalaco SJ, et al. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child. J Neuropathol Exp Neurol. 2005;64(6):545–552. PubMed PMC
Pilson K, Farrell M, Lynch B, Devaney D. A case of juvenile onset neuronal intranuclear inclusion disease with a negative antemortem skin biopsy. Pediatr Dev Pathol. 2018;21(5):494–496. PubMed
Patel H, Norman MG, Perry TL, Berry KE. Multiple system atrophy with neuronal intranuclear hyaline inclusions. Report of a case and review of the literature. J Neurol Sci. 1985;67(1):57–65. PubMed
Sloane AE, Becker LE, Ang LC, Wark J, Haslam RH. Neuronal intranuclear hyaline inclusion disease with progressive cerebellar ataxia. Pediatr Neurol. 1994;10(1):61–66. PubMed
Oyer CE, Cortez S, O'Shea P, Popovic M. Cardiomyopathy and myocyte intranuclear inclusions in neuronal intranuclear inclusion disease: a case report. Hum Pathol. 1991;22(7):722–724. PubMed
Garen PD, Powers JM, Young GF, Lee V. Neuronal intranuclear hyaline inclusion disease in a nine year old. Acta Neuropathol. 1986;70(3–4):327–332. PubMed
Sone J, Mori K, Inagaki T, et al. Clinicopathological features of adult‐onset neuronal intranuclear inclusion disease. Brain. 2016;139(Pt 12):3170–3186. PubMed PMC
